C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.530
-0.120 (-4.53%)
At close: Nov 17, 2026, 4:00 PM EST
2.520
-0.010 (-0.40%)
After-hours: Nov 17, 2026, 7:41 PM EST

C4 Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
32.4374.655.5126.5929.7576.12
Short-Term Investments
172.97173.93189.41127.09246.4233.16
Cash & Short-Term Investments
205.4248.54244.9253.68276.15309.28
Cash Growth
7.04%1.48%-3.46%-8.14%-10.71%-16.79%
Receivables
1.412.43.111.81.475.72
Prepaid Expenses
7.77.179.765.719.9310.69
Total Current Assets
214.5258.11257.77271.19287.56325.69
Property, Plant & Equipment
4045.2863.3871.0977.5235.05
Long-Term Investments
69.2948.5622.3628.0160.96142.2
Other Long-Term Assets
8.017.136.16.174.813.82
Total Assets
331.8359.08349.6376.45430.84506.77

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.960.861.331.451.174.51
Accrued Expenses
13.1511.9217.4915.4916.6613.19
Current Portion of Long-Term Debt
----2.29-
Current Portion of Leases
6.846.375.775.224.71.33
Current Unearned Revenue
19.5212.4918.7115.4716.6231.8
Other Current Liabilities
0.991.41.875.143.110.41
Total Current Liabilities
41.4633.0345.1842.7744.5551.25
Long-Term Debt
----9.210.77
Long-Term Leases
48.4153.6259.9865.7670.9730.78
Long-Term Unearned Revenue
13.7715.8428.4621.8116.924.37
Total Liabilities
103.63102.49133.62130.34141.61117.16

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010.01
Additional Paid-In Capital
1,039995.22849.63774.62689.26658.09
Retained Earnings
-809.3-738.69-633.7-528.38-395.89-267.72
Comprehensive Income & Other
-1.060.050.05-0.13-4.14-0.78
Total Common Equity
228.17256.59215.99246.11289.23389.61
Shareholders' Equity
228.17256.59215.99246.11289.23389.61
Total Liabilities & Equity
331.8359.08349.6376.45430.84506.77

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
55.2559.9865.7670.9887.1542.88
Net Cash (Debt)
219.44237.12201.51210.71249.96408.6
Net Cash Growth
58.67%17.67%-4.37%-15.70%-38.82%17.16%
Net Cash Per Share
1.722.862.904.245.128.87
Filing Date Shares Outstanding
131.3297.5870.9968.649.0548.74
Total Common Shares Outstanding
131.3196.9170.6360.4748.9748.69
Working Capital
173.04225.08212.59228.42243.01274.44
Book Value Per Share
1.742.653.064.075.918.00
Tangible Book Value
228.17256.59215.99246.11289.23389.61
Tangible Book Value Per Share
1.742.653.064.075.918.00
Machinery
11.0410.9710.3710.1810.669.48
Construction In Progress
----0.18-
Leasehold Improvements
4.554.554.714.714.680.54
SEC Filings: 10-K · 10-Q